# Quibim, S.L.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/quibim-s-l

- Industry: Biotechnology
- Headquarters: Valencia, Spain
- Website: www.quibim.com/
- Total disclosed funding: $59M
- Latest round: Series A (Jan 16, 2025)
- Investors on record: 17

## About

Headquartered in Valencia, Spain, Quibim, S.L. specializes in artificial intelligence solutions tailored for medical imaging, enhancing diagnostic precision and aiding healthcare providers in patient outcomes.Quibim, S.L. was established in 2015 in Valencia, Spain, focusing on AI-driven medical imaging solutions. The company does not have known subsidiaries or parent companies and has undergone strategic pivots to enhance its product offerings. Ángel Alberich-Bayarri is the founder and also serves as the CEO. Quibim raised EUR 47.9 mn in a Series A funding round on January 16, 2025, with support from investors such as Adara Ventures and Amadeus Capital Partners. The company has successfully completed a total of 9 investment deals to date.Quibim offers a range of advanced artificial intelligence products for medical imaging, including QP-Prostate®, QP-Brain®, QP-Liver®, and QP-Insights®. These solutions aim to improve diagnostic accuracy and streamline data management for hospitals and research institutions primarily in North America and Europe.In the most recent fiscal year, 2023, Quibim reported revenues of EUR 2,094,654.10, with an EBITDA of EUR -4,728,293.80, reflecting their ongoing investment in product development and market expansion.Following the successful Series A funding of EUR 47.9 mn in January 2025, Quibim plans to utilize these resources to enhance its product pipeline and accelerate global growth. The company is particularly focused on expanding into the U.S. market by forming partnerships with hospitals and pharmaceutical companies. With these initiatives, Quibim aims to solidify its presence in new regions and enhance its offerings in the medical imaging landscape.

## Funding rounds

- Series A, Jan 16, 2025, $49M — Amadeus Capital Partners, Partech Partners, Buenavista Equity Partners, Adara Ventures, UI Investissement, Center for Technological & Industrial Development, Kanoar Ventures, Apex Ventures, Asabys Partners, GoHub Ventures, Build Collective
- Seed, Jul 21, 2020, $9.2M — Amadeus Capital Partners, Partech Partners, Adara Ventures, Clave Capital, Apex Ventures, Tech Transfer UPV, Crista Galli Ventures
- Seed, Jul 28, 2017, $0.2M — Angels Capital
- Seed, Dec 27, 2016, $0.6M — Clave Capital, Ayce Capital, BioInfoGate S.L.

## Investors

- Clave Capital — Seed
- Ayce Capital — Seed
- BioInfoGate S.L. — Seed
- Angels Capital (https://capitalatlas.ai/funds/angels-capital) — Seed
- Amadeus Capital Partners (https://capitalatlas.ai/funds/amadeus-capital-partners) — Seed, Series A
- Partech Partners (https://capitalatlas.ai/funds/partech-partners) — Seed, Series A
- Adara Ventures (https://capitalatlas.ai/funds/adara-ventures) — Seed, Series A
- Apex Ventures (https://capitalatlas.ai/funds/apex-ventures) — Seed, Series A
- Tech Transfer UPV — Seed
- Crista Galli Ventures (https://capitalatlas.ai/funds/crista-galli-ventures) — Seed
- Buenavista Equity Partners (https://capitalatlas.ai/funds/buenavista-equity-partners) — Series A
- UI Investissement (https://capitalatlas.ai/funds/ui-investissement) — Series A
- Center for Technological & Industrial Development (https://capitalatlas.ai/funds/center-for-technological-industrial-development) — Series A
- Kanoar Ventures (https://capitalatlas.ai/funds/kanoar-ventures) — Series A
- Asabys Partners (https://capitalatlas.ai/funds/asabys-partners) — Series A
- GoHub Ventures (https://capitalatlas.ai/funds/gohub-ventures) — Series A
- Build Collective (https://capitalatlas.ai/funds/build-collective) — Series A
